Tarnished HALO For Targacept/AstraZeneca Schizophrenia Drug
Partners halt development of AZD3480 in schizophrenia after Phase II failure, but will wait for ADHD trial before deciding the fate of the compound.
Partners halt development of AZD3480 in schizophrenia after Phase II failure, but will wait for ADHD trial before deciding the fate of the compound.